285 related articles for article (PubMed ID: 26760999)
1. Antiproliferative Activity of Double Point Modified Analogs of 1,25-Dihydroxyvitamin D₂ Against Human Malignant Melanoma Cell Lines.
Piotrowska A; Wierzbicka J; Nadkarni S; Brown G; Kutner A; Żmijewski MA
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26760999
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative activity of side-chain truncated vitamin D analogs (PRI-1203 and PRI-1204) against human malignant melanoma cell lines.
Piotrowska A; Wierzbicka J; Kwiatkowska K; Chodyński M; Kutner A; Żmijewski MA
Eur J Pharmacol; 2020 Aug; 881():173170. PubMed ID: 32445704
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative Activity of Non-Calcemic Vitamin D Analogs on Human Melanoma Lines in Relation to VDR and PDIA3 Receptors.
Wasiewicz T; Piotrowska A; Wierzbicka J; Slominski AT; Zmijewski MA
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30200275
[TBL] [Abstract][Full Text] [Related]
4. In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and -resistant melanoma cells.
Reichrath J; Rech M; Moeini M; Meese E; Tilgen W; Seifert M
Cancer Biol Ther; 2007 Jan; 6(1):48-55. PubMed ID: 17172823
[TBL] [Abstract][Full Text] [Related]
5. Novel analogs of 1,25-dihydroxyvitamin D
Nachliely M; Sharony E; Kutner A; Danilenko M
J Steroid Biochem Mol Biol; 2016 Nov; 164():59-65. PubMed ID: 26365556
[TBL] [Abstract][Full Text] [Related]
6. Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines.
Essa S; Reichrath S; Mahlknecht U; Montenarh M; Vogt T; Reichrath J
Anticancer Res; 2012 Jan; 32(1):383-9. PubMed ID: 22213330
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effects of vitamin D analogs on hamster and mouse melanoma cell lines in relation to melanin pigmentation.
Wasiewicz T; Szyszka P; Cichorek M; Janjetovic Z; Tuckey RC; Slominski AT; Zmijewski MA
Int J Mol Sci; 2015 Mar; 16(4):6645-67. PubMed ID: 25811927
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative Activity and in Vivo Toxicity of Double-Point Modified Analogs of 1,25-Dihydroxyergocalciferol.
Trynda J; Turlej E; Milczarek M; Pietraszek A; Chodyński M; Kutner A; Wietrzyk J
Int J Mol Sci; 2015 Oct; 16(10):24873-94. PubMed ID: 26492238
[TBL] [Abstract][Full Text] [Related]
9. VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells.
Essa S; Denzer N; Mahlknecht U; Klein R; Collnot EM; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):110-3. PubMed ID: 20153427
[TBL] [Abstract][Full Text] [Related]
10. Biological Evaluation of Double Point Modified Analogues of 1,25-Dihydroxyvitamin D₂ as Potential Anti-Leukemic Agents.
Corcoran A; Nadkarni S; Yasuda K; Sakaki T; Brown G; Kutner A; Marcinkowska E
Int J Mol Sci; 2016 Feb; 17(2):. PubMed ID: 26840307
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D and its low calcemic analogs modulate the anticancer properties of cisplatin and dacarbazine in the human melanoma A375 cell line.
Piotrowska A; Wierzbicka J; Rybarczyk A; Tuckey RC; Slominski AT; Żmijewski MA
Int J Oncol; 2019 Apr; 54(4):1481-1495. PubMed ID: 30968156
[TBL] [Abstract][Full Text] [Related]
12. Structure-function analysis of vitamin D(2) analogs as potential inducers of leukemia differentiation and inhibitors of prostate cancer proliferation.
Baurska H; Klopot A; Kielbinski M; Chrobak A; Wijas E; Kutner A; Marcinkowska E
J Steroid Biochem Mol Biol; 2011 Aug; 126(1-2):46-54. PubMed ID: 21550403
[TBL] [Abstract][Full Text] [Related]
13. Convergent synthesis of double point modified analogs of 1α,25-dihydroxyvitamin D
Nadkarni S; Chodyński M; Krajewski K; Cmoch P; Marcinkowska E; Brown G; Kutner A
J Steroid Biochem Mol Biol; 2016 Nov; 164():45-49. PubMed ID: 26316152
[TBL] [Abstract][Full Text] [Related]
14. Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitro.
Seifert M; Rech M; Meineke V; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):375-9. PubMed ID: 15225804
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, CYP24A1-Dependent Metabolism and Antiproliferative Potential against Colorectal Cancer Cells of 1,25-Dihydroxyvitamin D
Milczarek M; Chodyński M; Pietraszek A; Stachowicz-Suhs M; Yasuda K; Sakaki T; Wietrzyk J; Kutner A
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963716
[TBL] [Abstract][Full Text] [Related]
16. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
Skowronski RJ; Peehl DM; Feldman D
Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D receptor and growth inhibition by 1,25-dihydroxyvitamin D3 in human malignant melanoma cell lines.
Evans SR; Houghton AM; Schumaker L; Brenner RV; Buras RR; Davoodi F; Nauta RJ; Shabahang M
J Surg Res; 1996 Feb; 61(1):127-33. PubMed ID: 8769954
[TBL] [Abstract][Full Text] [Related]
18. Prodifferentiation Activity of Novel Vitamin D₂ Analogs PRI-1916 and PRI-1917 and Their Combinations with a Plant Polyphenol in Acute Myeloid Leukemia Cells.
Nachliely M; Sharony E; Bolla NR; Kutner A; Danilenko M
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399677
[TBL] [Abstract][Full Text] [Related]
19. Studies on the mechanisms of superagonistic pro-differentiating activities of side-chain modified analogs of vitamin D2.
Baurska H; Marchwicka A; Kłopot A; Kutner A; Marcinkowska E
Oncol Rep; 2012 Sep; 28(3):1110-6. PubMed ID: 22751936
[TBL] [Abstract][Full Text] [Related]
20. Targeting the vitamin D endocrine system (VDES) for the management of inflammatory and malignant skin diseases: An historical view and outlook.
Reichrath J; Zouboulis CC; Vogt T; Holick MF
Rev Endocr Metab Disord; 2016 Sep; 17(3):405-417. PubMed ID: 27447175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
